Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$13.81 - $23.25 $2.41 Million - $4.06 Million
-174,785 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$17.65 - $24.16 $3.08 Million - $4.22 Million
174,785 New
174,785 $3.66 Million
Q4 2020

Feb 16, 2021

SELL
$12.83 - $17.84 $288,636 - $401,346
-22,497 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.01 - $18.52 $247,691 - $416,644
22,497 New
22,497 $382,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.